| 1 |
32219694 | In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug-drug interactions. | 2020 Jun |
2 |
| 2 |
32279279 | The atypical neuroleptics iloperidone and lurasidone inhibit human cytochrome P450 enzymes in vitro. Evaluation of potential metabolic interactions. | 2020 Dec |
1 |
| 3 |
32941854 | Asenapine and iloperidone decrease the expression of major cytochrome P450 enzymes CYP1A2 and CYP3A4 in human hepatocytes. A significance for drug-drug interactions during combined therapy. | 2020 Nov 1 |
1 |
| 4 |
29989011 | Inhibition of cytochrome P450 enzymes by thymoquinone in human liver microsomes. | 2018 Jul |
1 |
| 5 |
27323294 | Simultaneous evaluation of substrate-dependent CYP3A inhibition using a CYP3A probe substrates cocktail. | 2016 Sep |
1 |
| 6 |
25864949 | A simple construction of electrochemical liver microsomal bioreactor for rapid drug metabolism and inhibition assays. | 2015 |
2 |
| 7 |
26481538 | Inhibition of human cytochrome P450 isoenzymes by a phenothiazine neuroleptic levomepromazine: An in vitro study. | 2015 Dec |
1 |
| 8 |
24117377 | Cytochrome P450 modified polycrystalline indium tin oxide film as a drug metabolizing electrochemical biosensor with a simple configuration. | 2013 Nov 5 |
1 |
| 9 |
22050110 | Clinical significance of steroid and xenobiotic receptor and its targeted gene CYP3A4 in human prostate cancer. | 2012 Feb |
2 |
| 10 |
22773874 | Oxidation of dihydrotestosterone by human cytochromes P450 19A1 and 3A4. | 2012 Aug 24 |
1 |
| 11 |
19326769 | Enzyme induction and cytotoxicity in human hepatocytes by chlorpyrifos and N,N-diethyl-m-toluamide (DEET). | 2008 |
1 |
| 12 |
17936932 | Human metabolic interactions of environmental chemicals. | 2007 |
2 |
| 13 |
14630070 | Phase I and phase II metabolic activities are retained in liver slices from mouse, rat, dog, monkey and human after cryopreservation. | 2004 Feb |
1 |
| 14 |
20945304 | Human cytochrome P450: metabolism of testosterone by CYP3A4 and inhibition by ketoconazole. | 2004 Jun |
1 |
| 15 |
12936704 | Identification of CYP3A4 and CYP2C8 as the major cytochrome P450 s responsible for morphine N-demethylation in human liver microsomes. | 2003 Aug |
1 |
| 16 |
11037108 | Characterization of transgenic mouse strains using six human hepatic cytochrome P450 probe substrates. | 2000 Aug |
2 |
| 17 |
10460798 | Enhancement of cytochrome P-450 3A4 catalytic activities by cytochrome b(5) in bacterial membranes. | 1999 Sep |
1 |
| 18 |
9616193 | N-Dealkylation and hydroxylation of ebastine by human liver cytochrome P450. | 1998 Jun |
1 |
| 19 |
9820175 | Potent and non-specific inhibition of cytochrome P450 by JM216, a new oral platinum agent. | 1998 Nov |
1 |
| 20 |
9353130 | Drug metabolism in hepatocyte sandwich cultures of rats and humans. | 1997 Oct 1 |
2 |
| 21 |
7627274 | Young female patient with testosterone-producing adrenocortical adenoma also showing signs of subclinical Cushing's syndrome. | 1995 Apr |
1 |
| 22 |
1491046 | Improved sample preparation for the testosterone hydroxylation assay using disposable extraction columns. | 1992 Nov 6 |
2 |
| 23 |
2231265 | Inhibition of testosterone biosynthesis in testicular microsomes by various imidazole drugs. Comparative study with ketoconazole. | 1990 Jun |
1 |
| 24 |
2328827 | Testosterone lowers aromatase activity in cultured human genital skin fibroblasts. | 1990 Mar 5 |
1 |
| 25 |
2848247 | Isolation of a full-length cDNA insert encoding human aromatase system cytochrome P-450 and its expression in nonsteroidogenic cells. | 1988 Dec |
1 |
| 26 |
3129418 | Novel properties of human placental aromatase as cytochrome P-450: purification and characterization of a unique form of aromatase. | 1988 Jan |
1 |
| 27 |
3429444 | Purification of human liver cytochrome P-450 catalyzing testosterone 6 beta-hydroxylation. | 1987 Sep |
3 |
| 28 |
3493777 | Significance of cytochrome P-450 (P-450 HFLa) of human fetal livers in the steroid and drug oxidations. | 1987 Feb 15 |
1 |
| 29 |
611643 | The additive effects of progestins on testosterone-stimulated hepatic ethylmorphine metabolism and cytochrome P-450 content. | 1977 Dec |
1 |
| 30 |
1209686 | Differential inhibition of androst-4-en-3,17-dione aromatization by carbon monoxide in the presence of estr-4-en-3,17-dione. | 1975 Nov |
1 |
| 31 |
4831127 | Spironolactone and testicular cytochrome P-450: decreased testosterone formation in several species and changes in hepatic drug metabolism. | 1974 Jun |
1 |